Advisory Services Network’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-1,164
| Closed | -$18.9K | – | 3285 |
|
|
2026
Q1 | $18.9K | Buy |
+1,164
| New | +$19.5K | ﹤0.01% | 3235 |
|
|
2025
Q4 | – | Sell |
-852
| Closed | -$13.2K | – | 2911 |
|
|
2025
Q3 | $13.2K | Buy |
+852
| New | +$11.7K | ﹤0.01% | 3152 |
|
|
2024
Q1 | – | Sell |
-2,739
| Closed | -$36.9K | – | 2425 |
|
|
2023
Q4 | $36.9K | Buy |
+2,739
| New | +$33.7K | ﹤0.01% | 2177 |
|
|
2023
Q2 | – | Sell |
-3,643
| Closed | -$50.7K | – | 2412 |
|
|
2023
Q1 | $50.7K | Hold |
3,643
| – | – | ﹤0.01% | 2010 |
|
|
2022
Q4 | $51.8K | Buy |
+3,643
| New | +$52.8K | ﹤0.01% | 1959 |
|
|
2021
Q3 | – | Sell |
-2,685
| Closed | -$58K | – | 2217 |
|
|
2021
Q2 | $58K | Buy |
+2,685
| New | +$54.2K | ﹤0.01% | 1910 |
|
|
2021
Q1 | – | Sell |
-4,308
| Closed | -$85K | – | 2027 |
|
|
2020
Q4 | $85K | Sell |
4,308
-1,486
| -26% | -$27.5K | ﹤0.01% | 1398 |
|
|
2020
Q3 | $102K | Buy |
+5,794
| New | +$104K | ﹤0.01% | 1251 |
|
|
2020
Q2 | – | Sell |
-5,561
| Closed | -$83K | – | 1783 |
|
|
2020
Q1 | $83K | Buy |
5,561
+3,130
| +129% | +$51.2K | 0.01% | 1155 |
|
|
2019
Q4 | $42K | Sell |
2,431
-142
| -6% | -$2.33K | ﹤0.01% | 1585 |
|
|
2019
Q3 | $43K | Hold |
2,573
| – | – | ﹤0.01% | 1434 |
|
|
2019
Q2 | $43K | Sell |
2,573
-106
| -4% | -$1.75K | ﹤0.01% | 1432 |
|
|
2019
Q1 | $46K | Sell |
2,679
-9
| -0.3% | -$155 | ﹤0.01% | 1272 |
|
|
2018
Q4 | $41K | Buy |
2,688
+65
| +2% | +$1.15K | ﹤0.01% | 1215 |
|
|
2018
Q3 | $54K | Buy |
2,623
+44
| +2% | +$875 | ﹤0.01% | 1194 |
|
|
2018
Q2 | $51K | Sell |
2,579
-1
| -0% | -$19 | ﹤0.01% | 1205 |
|
|
2018
Q1 | $50K | Buy |
2,580
+39
| +2% | +$781 | ﹤0.01% | 1317 |
|
|
2017
Q4 | $50K | Buy |
2,541
+22
| +0.9% | +$441 | ﹤0.01% | 1272 |
|
|
2017
Q3 | $54K | Hold |
2,519
| – | – | 0.01% | 1073 |
|
|
2017
Q2 | $53K | Buy |
2,519
+235
| +10% | +$4.75K | 0.01% | 1029 |
|
|
2017
Q1 | $44K | Buy |
+2,284
| New | +$42.3K | 0.01% | 1026 |
|
|
2016
Q3 | $43K | Buy |
2,305
+910
| +65% | +$17.2K | 0.01% | 908 |
|
|
2016
Q2 | $24K | Buy |
1,395
+1,324
| +1,865% | +$24.4K | 0.01% | 978 |
|
|
2016
Q1 | $1K | Sell |
71
-1,600
| -96% | -$29K | ﹤0.01% | 1588 |
|
|
2015
Q4 | $40K | Buy |
1,671
+1,645
| +6,327% | +$40.8K | 0.01% | 628 |
|
|
2015
Q3 | $1K | Hold |
26
| – | – | ﹤0.01% | 1418 |
|
|
2015
Q2 | $1K | Hold |
26
| – | – | ﹤0.01% | 1337 |
|
|
2015
Q1 | $1K | Hold |
26
| – | – | ﹤0.01% | 1240 |
|
|
2014
Q4 | $1K | Buy |
+26
| New | +$624 | ﹤0.01% | 1158 |
|
|
2014
Q1 | – | Sell |
-336
| Closed | -$7K | – | 462 |
|
|
2013
Q4 | $7K | Buy |
+336
| New | +$6.52K | ﹤0.01% | 691 |
|
Other funds holding HQL
PCM
NIM
FHA
AAM
1WA
Advisory Services Network's HQL Position: Q2 2026 in Review
Advisory Services Network sold out of abrdn Life Sciences Investors (HQL) in Q2 2026, closing a stake of 1,164 shares — an estimated $18.9K sold.
Advisory Services Network first reported a position in HQL in Q4 2013 and held it in 30 quarters. The position peaked at $102K in Q3 2020. 83 funds tracked by Wall St. Rank hold HQL as of Q2 2026.
- Advisory Services Network reported no remaining abrdn Life Sciences Investors position as of Q2 2026 after selling out during the quarter.
- Advisory Services Network sold 1,164 abrdn Life Sciences Investors shares in Q2 2026, an estimated $18.9K.
- Advisory Services Network first reported a position in abrdn Life Sciences Investors in Q4 2013 and held it in 30 quarters.
- Advisory Services Network's abrdn Life Sciences Investors position peaked at $102K in Q3 2020.
- 83 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.
Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.